Secondary prevention using antioxidants of cardiovascular disease in endstage renal disease: SPACE

被引：0
|
作者：
Boat, M
Smetana, S
Weinstein, T
Matas, Z
Gafter, U
Iaina, A
Knecht, A
Weissgarten, Y
Fainaru, M
Green, M
机构：
[1] E Wolfson Med Ctr, Dept Nephrol, Holon, Israel
[2] Rabin Med Ctr, Dept Nephrol, Petach Tikvah, Israel
[3] E Wolfson Med Ctr, Biochem Lab, Holon, Israel
[4] Ichilov Med Ctr, Dept Nephrol, Tel Aviv, Israel
[5] Chaim Sheba Med Ctr, Dept Nephrol, IL-52621 Tel Hashomer, Israel
[6] Asaf Harofeh Med Ctr, Dept Nephrol, Zrifin, Israel
[7] Sackler Fac Med, Lipid Res Lab, TAU, Ramat Aviv, Israel
[8] Israel Ctr Dis Control, Tel Hashomer, Israel
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2387
引用
收藏
页码：458 / 458
页数：1
相关论文
共 50 条
  • [1] Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
    Boaz, M
    Smetana, S
    Weinstein, T
    Matas, Z
    Gafter, U
    Iaina, A
    Knecht, A
    Weissgarten, Y
    Brunner, D
    Fainaru, M
    Green, MS
    [J]. LANCET, 2000, 356 (9237): : 1213 - 1218
  • [2] Antioxidants in the prevention of cardiovascular disease
    Páramo, JA
    Orbe, J
    Rodríguez, JA
    [J]. MEDICINA CLINICA, 2001, 116 (16): : 629 - 635
  • [3] Antioxidants in the prevention of renal disease
    Wardle, EN
    [J]. RENAL FAILURE, 1999, 21 (06) : 581 - 591
  • [4] Antioxidants in the prevention of renal disease
    Singh, Devinder
    Kaur, Rajnendrapal
    Chander, Vikas
    Chopra, Kanwaljlt
    [J]. JOURNAL OF MEDICINAL FOOD, 2006, 9 (04) : 443 - 450
  • [5] Apolipoprotein B Attenuates Albuminuria-Associated Cardiovascular Disease in Prevention of Renal and Vascular Endstage Disease (PREVEND) Participants
    Corsetti, James P.
    Gansevoort, Ron T.
    Bakker, Stephan J. L.
    Sparks, Charles E.
    Vart, Priya
    Dullaart, Robin P. F.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (12): : 2906 - 2915
  • [6] Albuminuria, Estimated GFR, Traditional Risk Factors, and Incident Cardiovascular Disease: The PREVEND (Prevention of Renal and Vascular Endstage Disease) Study
    Smink, Paul A.
    Lambers Heerspink, Hiddo J.
    Gansevoort, Ron T.
    de Jong, Paul E.
    Hillege, Hans L.
    Bakker, Stephan J. L.
    de Zeeuw, Dick
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (05) : 804 - 811
  • [7] Diuretics in endstage renal disease
    Dorfler, A
    [J]. NIEREN-UND HOCHDRUCKKRANKHEITEN, 1996, 25 (06) : 260 - 265
  • [8] Cardiovascular Disease in Women Primary and Secondary Cardiovascular Disease Prevention
    Sanghavi, Monika
    Gulati, Martha
    [J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2016, 43 (02) : 265 - +
  • [9] β-blocker in secondary prevention of cardiovascular disease
    Sauer, G
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 2003, 92 (01): : 24 - 30
  • [10] HRT as secondary prevention of cardiovascular disease
    Ylikorkala, A
    [J]. MATURITAS, 2004, 47 (04) : 315 - 318
12345